Keytruda Copay Card Information and Resources Available

The Keytruda copay card is a valuable resource for patients who are struggling to afford their medication. Eligible patients can receive a copay card that can help reduce their out-of-pocket costs.

The copay card can help patients save up to $13,900 per year on their Keytruda medication. This can be a significant reduction in costs for patients who are already facing financial burdens.

To be eligible for the copay card, patients must meet certain income and insurance requirements. Patients can visit the Keytruda website to learn more about the copay card program and to see if they qualify.

Merck offers the Merck Access Program to help with insurance and coverage questions after being prescribed Keytruda. This program provides information and resources that can be helpful to patients.

AstraZeneca has a patient assistance program called Access 360, which provides access to their medicines. They also have a co-pay savings program for eligible patients receiving select AstraZeneca specialty medications.

Genentech has a patient assistance program called Genentech Access Solutions, which includes a co-pay card for commercially insured patients and co-pay assistance foundations for patients with difficulty paying their co-pay.

Merck offers a Co-pay Assistance Program for patients prescribed KEYTRUDA, which helps with out-of-pocket costs.

Eligible patients pay the first $25 of their co-pay per infusion, and the maximum benefit per patient is $25,000.

The Merck Access Program provides information and resources to help patients understand insurance and coverage for KEYTRUDA.

You can call 1-855-257-3932 to get in touch with the Merck Access Program or visit merckaccessprogram-keytruda.com for more information.

The KEY+YOU program is designed to support patients prescribed KEYTRUDA, offering educational resources and tools to help them understand their treatment and care.

MyHealthcareFinances is a tool provided by Merck to help patients better understand their healthcare finances and find ways to lower their costs.

AstraZeneca is a pharmaceutical company that has been offering patient assistance programs for over 30 years. They believe that making medicines is not enough, and that people who need those medicines should be able to get them.

AstraZeneca's Access 360 program provides patient assistance, but specific details about this program are not mentioned in the provided text.

The AZ&ME Prescription Savings Program is another initiative by AstraZeneca to help patients who are struggling to afford their medicines. To apply, you can contact 1-800-AZandME.

AstraZeneca's Co-pay Savings Program is also available for eligible patients receiving select specialty medications, and can help with out-of-pocket costs. You can find more information on AZpatientsupport.com.

AstraZeneca offers a range of products, including Calquence, Enhertu, Imfinzi, Imjudo, Lynparza, Tagrisso, and TruQap.

Genentech is dedicated to helping patients access the medicines they need, having helped over 2 million patients since starting their access and reimbursement support program almost 20 years ago.

Genentech offers various patient assistance programs through Genentech Access Solutions, including the Genentech BioOncology Co-Pay Card for commercially insured patients with certain eligibility criteria.

The Genentech Patient Foundation provides prescription medication free of charge to patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and meet specific criteria.

Genentech Access Solutions also refers patients to co-pay assistance foundations supporting their disease if they have difficulty paying their co-pay, co-insurance, or other expenses.

Genentech offers a range of infused products, including AVASTIN, GAZYVA, HERCEPTIN, KADCYLA, PERJETA, POLIVY, RITUXAN, and TECENTRIQ.

Oral products offered by Genentech include ALECENSA, COTELLIC, ERIVEDGE, GAVRETO, ROZLYTREK, TARCEVA, and VENCLEXTA, as well as ZELBORAF.

Genentech also offers subcutaneous products, such as HERCEPTIN HYLECTA, PHESGO, and RITUXAN HYCELA.

Novartis has a dedicated website for their Oncology Universal Co-pay Program, which can be accessed at copay.novartisoncology.com.

Elizabeth Gugliotta, Associate Director of Access & Reimbursement at Novartis, is a key contact for those looking to learn more about the company's programs.

Novartis also has a website for Healthcare Professionals (HCPs) at hcp.novartis.com/home, which provides valuable information and resources.

Julie Rogers, a Field Reimbursement Manager at Novartis, is another point of contact for those seeking support with reimbursement and access to Novartis medications.

The Merck Co-pay Assistance Program is available to eligible patients who need help affording the out-of-pocket costs for KEYTRUDA. This program offers assistance to privately insured patients who pay the first $25 of their co-pay per infusion.

Eligible patients can receive up to $25,000 in co-pay assistance per Eligibility Period. However, it's essential to note that co-pay assistance from the Merck Co-pay Assistance Program is not insurance, and restrictions apply.

To be eligible for the Merck Co-pay Assistance Program, patients must be residents of the United States, have private health insurance that provides coverage for KEYTRUDA, and have been prescribed KEYTRUDA for an FDA-approved indication.

Other organizations can also help with co-pay assistance, including the Cancer Care Co-Pay Foundation, The Leukemia and Lymphoma Society Co-Pay Assistance Program, and the Patient Advocate Foundation Co-Pay Relief Program.

These organizations, along with the Merck Co-pay Assistance Program, can help alleviate the financial burden of cancer treatment. By exploring these options, patients can better understand their treatment costs and make informed decisions about their care.

The following organizations offer co-pay assistance programs:

It's essential to note that each foundation has specific diagnostic and financial criteria that patients must meet to be eligible for assistance.

The Keytruda copay card can be a game-changer for those struggling to afford their medication.

The Keytruda copay card program is available to eligible patients with commercial insurance, offering significant savings on out-of-pocket costs.

A copay of $5 or less per injection is a common benefit, regardless of the patient's insurance plan.

Patients can also receive a maximum of 100 copays per calendar year, which can add up to substantial savings.

To apply for the Keytruda copay card, patients can visit the manufacturer's website or contact their healthcare provider's office.